Taylor & Francis

Georgi Makin, Editor of 3DMedNet, is joined by Jacob Koffler (University of California San Diego; CA, USA) as they discuss how 3D printing is being used in spinal cord injury research. As part of 3DMedNet’s special feature - 3D in focus: applications in neuro R&D – Georgi and Jacob explore 3D printing in neurology and neuroscience.

Find out more:

Georgi Makin is the Editor of 3DMedNet (www.3dmednet.com), a community website that unites the diverse and multifaceted world of medical 3D printing with the aim of advancing the field, together.

Jacob Koffler is a Bioengineer Neuroscientist working at the Center for Neural Repair within the School of Medicine at the University of California San Diego. Find out more about his work in the full interview on 3DMedNet: http://bit.ly/2LeBTLF

Find out more about the neuro applications of 3D printing via 3DMedNet (http://bit.ly/2UhRRJc) and discover more about neurology, neuroscience and regenerative medicine via our supporting sister sites, Neuro Central (www.neuro-central.com) and RegMedNet (www.regmednet.com).

BioTechniques Digital and Assistant Editors Abigail Sawyer and Tristan Free talk to Greg Mitchelotti of Metabolon about metabolomics, its potential applications in precision medicine and the new $4 million research collaboration with the Canadian Longitudinal Study of Aging and other Canadian institutions to identify biomarkers for frailty.

In this interview, hear from Catharina Brandsten, Head of Tissue Establishment and Kristina Runeberg, Site Head, at Takara Bio Europe, about deriving ethical and GMP-grade embryonic stem cells.

Hear more about the recent mass spectrometry product launches from SCIEX announced at ASMS 2019, including the new Acoustic Ejection Mass Spectrometry technology, in this interview with Neil Walsh (SCIEX; MA, USA).

Understanding automation in cell therapy manufacturing: an interview with Markus Gershater by Taylor & Francis Group

BioTechniques Digital and Assistant Editors Abigail Sawyer and Tristan Free talk to Theo Roth from the University of California San Francisco Marson Lab (CA, USA). Having recently made headlines for his work in T-cell engineering, Theo takes us through his groundbreaking CRISPR research, its potential impacts in CAR-T cell therapy and further afield, whilst also tackling the evolving ethics in gene editing and the potential benefits of using ssDNA over dsDNA for CRISPR techniques.

In this interview, David Harris (Charles River Laboratories; NC, USA) discusses the current global landscape for cell therapy, associated safety concerns and challenges, and preclinical animal models that are used to evaluate cellular therapies.

Discover more about the development of CAR-T cell therapies, their bioanalytical challenges and specialized antibody reagents that can be ustilized to overcome these in this interview with Michael Schwenkert (Bio-Rad Laboratories).

Abigail Sawyer and Tristan Free, from the BioTechniques digital team, speak to Head of Open Access Publishing at Future Science Group, Francesca Lake about antibodies: their advantages and flaws, pitfalls in their use and selecting the right antibodies for an experiment.

Eric Bonner (Eurofins) discusses the techniques he uses for assessing immunogenicity, key challenges and what the future may hold for the field in this podcast, exclusive to the Bioanalysis Zone Spotlight on immunogenicity.

You can find many more resources on immunogenicity via the immunogenicity Spotlight pages on Bioanalysis Zone: http://bit.ly/2J6w15F